Negotiations between Italian Prime Minister Giorgia Meloni‘s right-wing government and Elon Musk‘s SpaceX over a Starlink deal reportedly worth $1.6 billion are sparking outrage in Italy‘s ...

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ... IRCCS in Italy,” show that Enhertu could become a new standard of care ...

AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...

AstraZeneca announced that it is spending up to $1bn to acquire Belgian biotech firm EsoBiotec, which it says has the potential to "transform" cell therapy. EsoBiotec’s in vivo delivery platform, ...

The biotech company is able to genetically modify immune cells, making them capable of attacking tumors directly inside the ...

Pharmaceuticals major AstraZeneca said on Wednesday that its experimental treatment, camizestrant, improved survival in patients with an advanced form of breast cancer without the disease getting ...

The European stock markets were moving higher in Monday trading as The Stoxx Europe 600 rose 0.75%, Germany's DAX was up 0.61%, the FTSE 100 in London gained 0.58%, France's CAC 40 increased 0.50%, ...